Does pegylated interferon α-2b confer additional benefit in...

Nature Clinical Practice Oncology 2009 / 2 Vol. 6; Iss. 2

Does pegylated interferon α-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?

Kirkwood, John M, Tawbi, Hussein A, Tarhini, Ahmad A, Moschos, Stergios J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Language:
english
Journal:
Nature Clinical Practice Oncology
DOI:
10.1038/ncponc1297
Date:
February, 2009
File:
PDF, 156 KB
english, 2009
Conversion to is in progress
Conversion to is failed